{
  "url": "https://openlegislation.uk/eu-regulation-2016-793/article-2",
  "json_url": "https://openlegislation.uk/eu-regulation-2016-793/article-2.json",
  "legislation": "eur/2016/793",
  "legislation_title": "Regulation (EU) 2016/793 of the European Parliament and of the Council of 11 May 2016 to avoid trade diversion into the European Union of certain key medicines (codification)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2016-793",
  "path": "article/2",
  "kind": "article",
  "number": "2",
  "heading": null,
  "text": "1. The importation into Great Britain of tiered-priced products for the purposes of release for free circulation, export, or a special Customs procedure shall be prohibited.\n2. The following shall be exempted from the prohibition regarding tiered-priced products as set out in paragraph 1:\n(a) export of the tiered-priced products to countries of destination;\n(b) placing under a transit or storage procedure for the purpose of export of the tiered-priced products to a country of destination.\n(3.) In this Article—\n(a) ‘special Customs procedure’ has the meaning given by section 3(4) of the Taxation (Cross-border Trade) Act 2018;\n(b) ‘storage procedure’ has the meaning given by paragraph 2(1) of Schedule 2 to the Taxation (Cross-border Trade) Act 2018.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Art. 2(1) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(a)(i)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Word in Art. 2(1) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(a)(ii)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Art. 2(1) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(a)(iii)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Words in Art. 2(2)(a) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(b)(i)"
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Words in Art. 2(2)(b) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(b)(ii)"
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Words in Art. 2(2)(b) substituted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(b)(i)"
    },
    {
      "type": "F",
      "label": "F7",
      "text": "Art. 2(3) inserted (31.12.2020) by The Prevention of Trade Diversion (Key Medicines) (EU Exit) Regulations 2020 (S.I. 2020/1354), regs. 1, 2(3)(c)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2016/793/article/2",
    "retrieved_at": "2026-11-01T14:45:50.442523+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}